Arnatar Therapeutics

NEWS

3D. The Red rocket that soars high and different than other rockets. Startup business successful concept.

Startups

Arnatar Debuts With $52M To Advance RNA Therapies That Go Beyond Silencing

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare disease called Alagille syndrome.

August 25, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025

October 21, 2025

·

4 min read

Press Releases

Arnatar Therapeutics Emerges from Stealth and Announces Receipt of FDA Orphan Drug and Rare Pediatric Disease Designations for ART4

August 25, 2025

·

3 min read

JOBS